UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation

Nature immunology, 2022-05, Vol.23 (5), p.692-704

2022

Volltextzugriff (PDF)

HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma

Cell reports (Cambridge), 2019-04, Vol.27 (1), p.226-237.e4

2019

Volltextzugriff (PDF)

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Nature communications, 2023-03, Vol.14 (1), p.1610-1610, Article 1610

2023

Volltextzugriff (PDF)

Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma

Cancer immunology research, 2019-12, Vol.7 (12), p.1928-1943

2019

Volltextzugriff (PDF)

GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma

Cancer Immunology, Immunotherapy, 2020-01, Vol.69 (1), p.81-94

2020

Volltextzugriff (PDF)

Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate

Scientific reports, 2017-07, Vol.7 (1), p.5790-11, Article 5790

2017

Volltextzugriff (PDF)

Antigen-presenting B cells promote TCF-1 + PD1 - stem-like CD8 + T-cell proliferation in glioblastoma

Frontiers in immunology, 2024-01, Vol.14, p.1295218-1295218

2024

Volltextzugriff (PDF)

167 B-cell-based vaccination elicit potent immunity against glioblastoma

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A99-A101

2020

Volltextzugriff (PDF)

A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model

Molecular therapy. Oncolytics, 2017-06, Vol.5 (C), p.97-104

2017

Volltextzugriff (PDF)

Landscape of combination therapy trials in breast cancer brain metastasis

International journal of cancer, 2020-10, Vol.147 (7), p.1939-1952

2020

Volltextzugriff (PDF)

Repurposing autophagy regulators in brain tumors

International journal of cancer, 2022-07, Vol.151 (2), p.167-180

2022

Volltextzugriff (PDF)

Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma

The Journal of experimental medicine, 2021-01, Vol.218 (1)

2021

Volltextzugriff (PDF)

Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment

Nanomedicine, 2019-02, Vol.16, p.126-137

2019

Volltextzugriff (PDF)

Genes that Mediate Metastasis across the Blood-Brain Barrier

Trends in Cancer, 2020-08, Vol.6 (8), p.660-676

2020

Volltextzugriff (PDF)

EXTH-29. DUAL TGFB AND PD1 BLOCKADE PROMOTES GERMINAL-CENTER B-CELL IMMUNE RESPONSES AGAINST GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi169-vi169

2021

Volltextzugriff (PDF)

TMIC-42. LEVERAGING B CELL IMMUNITY TO PROMOTE IMMUNOTHERAPY IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii280-vii280

2022

Volltextzugriff (PDF)

IMMU-43. POLYAMINE METABOLISM REGULATES MYELOID IMMUNE SUPPRESSION IN GLIOBLASTOMA

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi128-vi128

2019

Volltextzugriff (PDF)

Anti-GITR therapy promotes immunity against malignant glioma in a murine model

Cancer Immunology, Immunotherapy, 2016-12, Vol.65 (12), p.1555-1567

2016

Volltextzugriff (PDF)

Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases

The Journal of clinical investigation, 2023-12, Vol.133 (24), p.1-17

2023

Volltextzugriff (PDF)

Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations

Clinical breast cancer, 2019-12, Vol.19 (6), p.383-391

2019

Volltextzugriff (PDF)

Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer

Proceedings of the National Academy of Sciences - PNAS, 2022-01, Vol.119 (1)

2022

Volltextzugriff (PDF)

IMMU-29. B-CELL-BASED VACCINE PRODUCES GLIOBLASTOMA-REACTIVE ANTIBODIES THAT CONTRIBUTE TO TUMOR CLEARANCE

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi98-vi98

2021

Volltextzugriff (PDF)

IMMU-36. B CELL-VACCINE ELICITS LONG TERM IMMUNITY AGAINST GLIOBLASTOMA VIA ACTIVATION AND DIFFERENTIATION OF TUMOR-SPECIFIC CD8+ MEMORY T CELLS

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi100-vi100

2021

Volltextzugriff (PDF)

TAMI-25. UPREGULATION OF CREATINE METABOLISM BY MYELOID CELLS RESULTS IN GLIOBLASTOMA PROGRESSION

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi203-vi203

2021

Volltextzugriff (PDF)

TMET-14. TUMOR-ASSOCIATED MYELOID CELL-DERIVED CREATINE PROMOTES GLIOBLASTOMA GROWTH IN HYPOXIC NICHES AND PSEUDOPALISADING TUMOR REGIONS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii264-vii264

2022

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Mitochondrial electron transport chain is necessary for NLRP3 inflammasome activation

HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma

Myeloid-Derived Suppressive Cells Promote B cell-Mediated Immunosuppression via Transfer of PD-L1 in Glioblastoma

GCN2 is essential for CD8+ T cell survival and function in murine models of malignant glioma

Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate

Antigen-presenting B cells promote TCF-1 + PD1 - stem-like CD8 + T-cell proliferation in glioblastoma

167 B-cell-based vaccination elicit potent immunity against glioblastoma

A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model

Landscape of combination therapy trials in breast cancer brain metastasis

Repurposing autophagy regulators in brain tumors

Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma

Repolarization of myeloid derived suppressor cells via magnetic nanoparticles to promote radiotherapy for glioma treatment

Genes that Mediate Metastasis across the Blood-Brain Barrier

EXTH-29. DUAL TGFB AND PD1 BLOCKADE PROMOTES GERMINAL-CENTER B-CELL IMMUNE RESPONSES AGAINST GLIOBLASTOMA

TMIC-42. LEVERAGING B CELL IMMUNITY TO PROMOTE IMMUNOTHERAPY IN GLIOBLASTOMA

IMMU-43. POLYAMINE METABOLISM REGULATES MYELOID IMMUNE SUPPRESSION IN GLIOBLASTOMA

Anti-GITR therapy promotes immunity against malignant glioma in a murine model

Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases

Diagnostic Clinical Trials in Breast Cancer Brain Metastases: Barriers and Innovations

Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer

IMMU-29. B-CELL-BASED VACCINE PRODUCES GLIOBLASTOMA-REACTIVE ANTIBODIES THAT CONTRIBUTE TO TUMOR CLEARANCE

IMMU-36. B CELL-VACCINE ELICITS LONG TERM IMMUNITY AGAINST GLIOBLASTOMA VIA ACTIVATION AND DIFFERENTIATION OF TUMOR-SPECIFIC CD8+ MEMORY T CELLS

TAMI-25. UPREGULATION OF CREATINE METABOLISM BY MYELOID CELLS RESULTS IN GLIOBLASTOMA PROGRESSION

TMET-14. TUMOR-ASSOCIATED MYELOID CELL-DERIVED CREATINE PROMOTES GLIOBLASTOMA GROWTH IN HYPOXIC NICHES AND PSEUDOPALISADING TUMOR REGIONS

Suchergebnisse filtern